Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

The role of fibrinogen and fibrinogen concentrate in cardiac surgery: an international consensus statement from the Haemostasis and Transfusion Scientific Subcommittee of the European Association of Cardiothoracic Anaesthesiology

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Challenges in optimising recovery after emergency laparotomy

    Research output: Contribution to journalReviewResearchpeer-review

  2. Variation in the practice of tracheal intubation in Europe after traumatic brain injury: a prospective cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Enhanced postoperative recovery: good from afar, but far from good?

    Research output: Contribution to journalReviewResearchpeer-review

  4. The clinical implication of the association between hypoxaemia and postoperative troponin I: a reply

    Research output: Contribution to journalComment/debateResearchpeer-review

  1. Mechanical respiratory support in cardiogenic shock: reply

    Research output: Contribution to journalComment/debateResearchpeer-review

  2. Domain-specific cognitive dysfunction after cardiac surgery. A secondary analysis of a randomized trial

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Hypotension and Stroke in Cardiac Surgery: Comment

    Research output: Contribution to journalJournal articleResearchpeer-review

  • G Erdoes
  • A Koster
  • M I Meesters
  • E Ortmann
  • D Bolliger
  • E Baryshnikova
  • A Ahmed
  • M D Lance
  • H B Ravn
  • M Ranucci
  • C von Heymann
  • S Agarwal
View graph of relations

To date, data regarding the efficacy and safety of administering fibrinogen concentrate in cardiac surgery are limited. Studies are limited by their low sample size and large heterogeneity with regard to the patient population, by the timing of fibrinogen concentrate administration, and by the definition of transfusion trigger and target levels. Assessment of fibrinogen activity using viscoelastic point-of-care testing shortly before or after weaning from cardiopulmonary bypass in patients and procedures with a high risk of bleeding appears to be a rational strategy. In contrast, the use of Clauss fibrinogen test for determination of plasma fibrinogen level can no longer be recommended without restrictions due to its long turnaround time, high inter-assay variability and interference with high heparin levels and fibrin degradation products. Administration of fibrinogen concentrate for maintaining physiological fibrinogen activity in the case of microvascular post-cardiopulmonary bypass bleeding appears to be indicated. The available evidence does not suggest aiming for supranormal levels, however. Use of cryoprecipitate as an alternative to fibrinogen concentrate might be considered to increase plasma fibrinogen levels. Although conclusive evidence is lacking, fibrinogen concentrate does not seem to increase adverse outcomes (i.e., thromboembolic events). Large prospective multi-centre studies are needed to better define the optimal perioperative monitoring tool, transfusion trigger and target levels for fibrinogen replacement in cardiac surgery.

Original languageEnglish
JournalAnaesthesia
Volume74
Issue number12
Pages (from-to)1589-1600
Number of pages12
ISSN0003-2409
DOIs
Publication statusPublished - 2019

    Research areas

  • Anesthesiology, Cardiac Surgical Procedures/methods, Consensus, Fibrinogen/adverse effects, Homeostasis, Humans, Monitoring, Physiologic, Thoracic Surgery/methods

ID: 58987657